PLAINSBORO, N.J., June 6, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the pricing of $150 million aggregate principal amount of senior convertible notes due 2010 (the “2010 notes”) and $150 million aggregate principal amount of senior convertible notes due 2012 (the “2012 notes” and, together with the 2010 notes, the “notes”).